Turnover: 1.7 billion USD (2022)
Country: United States
Insulet is a company specializing in medical devices dedicated to improving the daily lives of people with diabetes. Its aim is to develop new technologies to simplify diabetes management.
Its main product is the Omnipod insulin management system, with software that downloads insulin administration data, blood glucose and carbohydrate values to create personalized reports of patient records.
Financial Data
DUNS: 837727387
Legal Name: INSULET FRANCE SAS
Address: 3 BD DE SEBASTOPOL , 75001 PARIS 1
Number of employees: Entre 10 et 19 salariés (2018)
Capital: 25 000 EUR
Financial Data:
| Year | Turnover (€) | Net Profit (€) | Fiscal Year End | Fiscal Year Duration |
|---|---|---|---|---|
| 2019 | 81 998 374 EUR | 1 728 639 EUR | 31/12/2019 | 12 |
| 2018 | 32 922 520 EUR | 674 036 EUR | 31/12/2018 | 11 |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Président | Bret | Christensen | 53 | |
| Directeur général | Wayde | Mc Millan | 54 |
Studies mentioning this company
The Insulin Pump Market - France
Other companies mentioned:
- Medtronic
- Cellnovo
- Roche Diabetes Care (Roche Groupe)
- Insulet
- Ypsomed Group
- ISIS diabète (Isis Médical)
- Physidia
- Nova Medical Center
- Medtrum
- Apex Wellell
- Open APS
- Eli Lilly
- TreeFrog Therapeutics
- Boydsense
> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)
Sector-GPT est la première IA dédiée aux informations sectorielles.